GAMCO Investors’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

GAMCO Investors’s Portfolio CERE Stock Details CERE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-59,350	Closed	-$2.43M	–	906
2024 Q2	$2.43M	Sell	59,350 -9,487	-14%	-$395K	0.03%	465
2024 Q1	$2.91M	Buy	68,837 +6,555	+11%	+$275K	0.03%	430
2023 Q4	$2.64M	Buy	+62,282	New	+$1.79M	0.03%	445

Other funds holding CERE

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

GAMCO Investors's CERE Position: Q3 2024 in Review

GAMCO Investors sold out of Cerevel Therapeutics Holdings, Inc. Common Stock (CERE) in Q3 2024, closing a stake of 59,350 shares — an estimated $2.43M sold.

GAMCO Investors first reported a position in CERE in Q4 2023 and held it in 3 quarters. The position peaked at $2.91M in Q1 2024. 2 funds tracked by Wall St. Rank hold CERE as of Q3 2024.

GAMCO Investors reported no remaining Cerevel Therapeutics Holdings, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
GAMCO Investors sold 59,350 Cerevel Therapeutics Holdings, Inc. Common Stock shares in Q3 2024, an estimated $2.43M.
GAMCO Investors first reported a position in Cerevel Therapeutics Holdings, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
GAMCO Investors's Cerevel Therapeutics Holdings, Inc. Common Stock position peaked at $2.91M in Q1 2024.
2 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Common Stock as of Q3 2024.

Based on GAMCO Investors's 13F filing for Q3 2024, filed 14 Nov 2024.